Abstract
Multivariate Efficacy Analysis of a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have